clinical trial of Pippali Rasayana and Nagaradi Kashaya Ghana Vati combination as an adjuvant treatment with ICMR guided medicines in Covid-19 positive mildly symptomatic cases
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/10/028230
- Lead Sponsor
- Government of India AYUSH EMR scheme
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1Patients with Covid -19 test positive (Confirmed using RT-PCR test)
2Covid-19 positive patients willing to participate in the study.
3Patients of either sex having age above 20 yrs. below 70 yrs.
4Covid-19 positive mildly symptomatic
1.Covid-19 positive patients having moderate to severe symptoms
2.Requiring immediate Intensive care.
3.Patients having complications of major illness such as Liver/Kidney failure
Encephalopathy, Epileptic attacks, Coagulopathies, Neuromuscular diseases, Cancer
4.Uncontrolled DM(HbA1C > 7.5) and its complications
5.Uncontrolled HTN and complications
6.Tuberculosis, Pleural Effusion, collapse of any lobe of Lung Ca Lung, COPD patients with dyspnea SPO2 <90, Respiratory rate > 20, requiring Nebulization frequently
7.Immunocompromised patients
8.Anemic patients having Hb <7 g/dl
9.BMI > 40
10.Pregnant and Lactating ladies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Covid-19 positive mildly symptomatic patients will turn Covid negative after administration of combination of Pippali Rasayana +Nagaradi Kashaya Ghana Vati along with the ICMR guided treatment <br/ ><br>Recovery from the symptoms will be early and significant after administration of Pippali Rasayana +Nagaradi Kashaya Ghana Vati in mildly symptomatic Covid 19 positive patients <br/ ><br> <br/ ><br>Timepoint: Day 0 Day 14 <br/ ><br>
- Secondary Outcome Measures
Name Time Method relief in associated symptoms if anyTimepoint: Day 0 Day 14